JANX
Price
$25.11
Change
+$0.14 (+0.56%)
Updated
Aug 15 closing price
Capitalization
1.51B
85 days until earnings call
TARA
Price
$3.03
Change
-$0.16 (-5.02%)
Updated
Aug 15 closing price
Capitalization
116.9M
73 days until earnings call
Interact to see
Advertisement

JANX vs TARA

Header iconJANX vs TARA Comparison
Open Charts JANX vs TARABanner chart's image
Janux Therapeutics
Price$25.11
Change+$0.14 (+0.56%)
Volume$527.34K
Capitalization1.51B
Protara Therapeutics
Price$3.03
Change-$0.16 (-5.02%)
Volume$229.84K
Capitalization116.9M
JANX vs TARA Comparison Chart in %
Loading...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JANX vs. TARA commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANX is a Hold and TARA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (JANX: $25.11 vs. TARA: $3.03)
Brand notoriety: JANX and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JANX: 66% vs. TARA: 73%
Market capitalization -- JANX: $1.51B vs. TARA: $116.9M
JANX [@Biotechnology] is valued at $1.51B. TARA’s [@Biotechnology] market capitalization is $116.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JANX’s FA Score shows that 0 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • JANX’s FA Score: 0 green, 5 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, TARA is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JANX’s TA Score shows that 6 TA indicator(s) are bullish while TARA’s TA Score has 3 bullish TA indicator(s).

  • JANX’s TA Score: 6 bullish, 4 bearish.
  • TARA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, JANX is a better buy in the short-term than TARA.

Price Growth

JANX (@Biotechnology) experienced а +9.99% price change this week, while TARA (@Biotechnology) price change was -3.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.77%. For the same industry, the average monthly price growth was +22.52%, and the average quarterly price growth was +23.13%.

Reported Earning Dates

JANX is expected to report earnings on Nov 11, 2025.

TARA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+8.77% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.51B) has a higher market cap than TARA($117M). TARA YTD gains are higher at: -42.614 vs. JANX (-53.100). TARA has higher annual earnings (EBITDA): -51.1M vs. JANX (-111.54M). JANX has more cash in the bank: 1.01B vs. TARA (124M). TARA has less debt than JANX: TARA (4.23M) vs JANX (22.6M). JANX has higher revenues than TARA: JANX (9.34M) vs TARA (0).
JANXTARAJANX / TARA
Capitalization1.51B117M1,290%
EBITDA-111.54M-51.1M218%
Gain YTD-53.100-42.614125%
P/E RatioN/AN/A-
Revenue9.34M0-
Total Cash1.01B124M818%
Total Debt22.6M4.23M535%
FUNDAMENTALS RATINGS
TARA: Fundamental Ratings
TARA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JANXTARA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LOGBX37.000.04
+0.11%
Scharf Multi-Asset Opportunity Retail
INKDX18.98N/A
N/A
Victory Pioneer Disciplined Growth R6
EATVX42.24-0.09
-0.21%
Eaton Vance Tx-Mgd Value A
SSSWX484.67-1.30
-0.27%
State Street Equity 500 Index I
DESUX24.70-0.11
-0.44%
DWS ESG Core Equity R6

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with TERN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+0.56%
TERN - JANX
37%
Loosely correlated
+4.14%
BNTX - JANX
36%
Loosely correlated
+0.66%
CRNX - JANX
36%
Loosely correlated
N/A
CYTK - JANX
35%
Loosely correlated
-0.13%
APGE - JANX
35%
Loosely correlated
-2.18%
More

TARA and

Correlation & Price change

A.I.dvisor tells us that TARA and ITRM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TARA and ITRM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
-5.02%
ITRM - TARA
31%
Poorly correlated
+5.26%
CDIO - TARA
31%
Poorly correlated
-9.77%
RNXT - TARA
29%
Poorly correlated
N/A
JANX - TARA
28%
Poorly correlated
+0.56%
OCUL - TARA
28%
Poorly correlated
-0.24%
More